Silo Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Silo Pharma has a total shareholder equity of $6.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.6M and $1.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.02m |
| Equity | US$6.78m |
| Total liabilities | US$1.78m |
| Total assets | US$8.57m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: SILO's short term assets ($8.3M) exceed its short term liabilities ($1.0M).
Long Term Liabilities: SILO's short term assets ($8.3M) exceed its long term liabilities ($739.6K).
Debt to Equity History and Analysis
Debt Level: SILO is debt free.
Reducing Debt: SILO has no debt compared to 5 years ago when its debt to equity ratio was 8.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SILO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SILO has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 36.4% each year.